Türeci Ö - Search Results

1

Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T_H1 T cell responses.

Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, Brachtendorf S, Lörks V, Sikorski J, Hilker R, Becker D, Eller AK, Grützner J, Boesler C, Rosenbaum C, Kühnle MC, Luxemburger U, Kemmer-Brück A, Langer D, Bexon M, Bolte S, Karikó K, Palanche T, Fischer B, Schultz A, Shi PY, Fontes-Garfias C, Perez JL, Swanson KA, Loschko J, Scully IL, Cutler M, Kalina W, Kyratsous CA, Cooper D, Dormitzer PR, Jansen KU, Türeci Ö. Sahin U, et al. Among authors: tureci o. Nature. 2021 Feb;590(7844):E17. doi: 10.1038/s41586-020-03102-w. Nature. 2021. PMID: 33469214 No abstract available.

2

SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.

Krause P, Türeci O, Micke P, Buhl R, Huber C, Sahin U. Krause P, et al. Among authors: tureci o. J Immunol Methods. 2003 Dec;283(1-2):261-7. doi: 10.1016/j.jim.2003.09.014. J Immunol Methods. 2003. PMID: 14659917

3

CrELISA: a fast and robust enzyme-linked immunosorbent assay bypassing the need for purification of recombinant protein.

Türeci O, Luxemburger U, Heinen H, Mack U, Sybrecht GW, Huber C, Sahin U. Türeci O, et al. J Immunol Methods. 2004 Jun;289(1-2):191-9. doi: 10.1016/j.jim.2004.04.020. J Immunol Methods. 2004. PMID: 15251424

4

Frequent nonrandom activation of germ-line genes in human cancer.

Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Müntefering H, Huber C, Sahin U, Türeci O. Koslowski M, et al. Among authors: tureci o. Cancer Res. 2004 Sep 1;64(17):5988-93. doi: 10.1158/0008-5472.CAN-04-1187. Cancer Res. 2004. PMID: 15342378

5

Identification of tumor-associated autoantigens with SEREX.

Türeci O, Usener D, Schneider S, Sahin U. Türeci O, et al. Methods Mol Med. 2005;109:137-54. doi: 10.1385/1-59259-862-5:137. Methods Mol Med. 2005. PMID: 15585919

6

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.

Türeci O, Mack U, Luxemburger U, Heinen H, Krummenauer F, Sester M, Sester U, Sybrecht GW, Sahin U. Türeci O, et al. Cancer Lett. 2006 May 8;236(1):64-71. doi: 10.1016/j.canlet.2005.05.008. Epub 2005 Jun 29. Cancer Lett. 2006. PMID: 15992994

7

The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes.

Koslowski M, Sahin U, Huber C, Türeci O. Koslowski M, et al. Among authors: tureci o. Hum Mol Genet. 2006 Aug 1;15(15):2392-9. doi: 10.1093/hmg/ddl163. Epub 2006 Jun 29. Hum Mol Genet. 2006. PMID: 16809397

8

Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues.

Klamp T, Sahin U, Kyewski B, Schwendemann J, Dhaene K, Türeci O. Klamp T, et al. Among authors: tureci o. Immunol Lett. 2006 Aug 15;106(2):172-9. doi: 10.1016/j.imlet.2006.06.006. Epub 2006 Jul 28. Immunol Lett. 2006. PMID: 16876259

9

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Türeci O, Sahin U. Holtkamp S, et al. Among authors: tureci o. Blood. 2006 Dec 15;108(13):4009-17. doi: 10.1182/blood-2006-04-015024. Epub 2006 Aug 29. Blood. 2006. PMID: 16940422 Free article.

10

Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA.

Kreiter S, Konrad T, Sester M, Huber C, Türeci O, Sahin U. Kreiter S, et al. Among authors: tureci o. Cancer Immunol Immunother. 2007 Oct;56(10):1577-87. doi: 10.1007/s00262-007-0302-7. Epub 2007 Mar 15. Cancer Immunol Immunother. 2007. PMID: 17361438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page